AU3481001A - Taxane formulations having improved solubility - Google Patents

Taxane formulations having improved solubility Download PDF

Info

Publication number
AU3481001A
AU3481001A AU34810/01A AU3481001A AU3481001A AU 3481001 A AU3481001 A AU 3481001A AU 34810/01 A AU34810/01 A AU 34810/01A AU 3481001 A AU3481001 A AU 3481001A AU 3481001 A AU3481001 A AU 3481001A
Authority
AU
Australia
Prior art keywords
pyridyl
thienyl
furyl
substituted
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34810/01A
Other languages
English (en)
Inventor
Robert A. Holton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University Research Foundation Inc
Original Assignee
Florida State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation Inc filed Critical Florida State University Research Foundation Inc
Publication of AU3481001A publication Critical patent/AU3481001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU34810/01A 2000-02-02 2001-02-02 Taxane formulations having improved solubility Abandoned AU3481001A (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US17967400P 2000-02-02 2000-02-02
US17966900P 2000-02-02 2000-02-02
US17978200P 2000-02-02 2000-02-02
US17967100P 2000-02-02 2000-02-02
US17967000P 2000-02-02 2000-02-02
US17979300P 2000-02-02 2000-02-02
US17968400P 2000-02-02 2000-02-02
US17967200P 2000-02-02 2000-02-02
US60179672 2000-02-02
US60179782 2000-02-02
US60179670 2000-02-02
US60179671 2000-02-02
US60179794 2000-02-02
US60179669 2000-02-02
US60179793 2000-02-02
US60179684 2000-02-02
PCT/US2001/003624 WO2001057013A1 (en) 2000-02-02 2001-02-02 Taxane formulations having improved solubility

Publications (1)

Publication Number Publication Date
AU3481001A true AU3481001A (en) 2001-08-14

Family

ID=27575082

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34810/01A Abandoned AU3481001A (en) 2000-02-02 2001-02-02 Taxane formulations having improved solubility

Country Status (9)

Country Link
EP (1) EP1175414A1 (hu)
KR (1) KR20010111580A (hu)
AU (1) AU3481001A (hu)
BR (1) BR0104358A (hu)
HU (1) HUP0200995A3 (hu)
IL (1) IL145635A0 (hu)
NO (1) NO20014752L (hu)
NZ (1) NZ514073A (hu)
WO (1) WO2001057013A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2368534A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
TR200102855T1 (tr) 2000-02-02 2002-06-21 Florida State University Research Foundation, Inc Antitümör ajanları olarak C10 karbonat ikameli taksanlar.
RU2265019C2 (ru) 2000-02-02 2005-11-27 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксаны, фармацевтические композиции, способы ингибирования
CN1362876A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C10杂取代的乙酸基紫衫烷抗肿瘤剂
NZ514407A (en) 2000-02-02 2004-12-24 Univ Florida State Res Found C10 carbamoyloxy substituted taxanes as antitumor agents
CA2354478A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2004013093A2 (en) 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
SV2006002010A (es) 2004-02-13 2006-08-23 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
GT200500041A (es) 2004-03-05 2005-10-24 Taxanos con sustituyente lactiloxilo en el c7
EP2276755A4 (en) * 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
CA2174350A1 (en) * 1993-10-20 1995-04-27 Richard B. Greenwald 2'- and/or 7- substituted taxoids
JPH10508022A (ja) * 1994-10-28 1998-08-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5801191A (en) * 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
KR100476247B1 (ko) * 1996-07-15 2005-03-10 가부시키가이샤 야쿠루트 혼샤 탁산 유도체 및 그를 함유하는 의약
JPH1192468A (ja) * 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
WO1999032473A1 (fr) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Derives de taxane
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
HUP0200995A3 (en) 2005-02-28
HUP0200995A2 (hu) 2002-07-29
NZ514073A (en) 2004-02-27
EP1175414A1 (en) 2002-01-30
NO20014752L (no) 2001-11-27
KR20010111580A (ko) 2001-12-19
BR0104358A (pt) 2002-01-02
WO2001057013A1 (en) 2001-08-09
IL145635A0 (en) 2002-06-30
NO20014752D0 (no) 2001-10-01

Similar Documents

Publication Publication Date Title
AU776051B2 (en) C7 ester substituted taxanes as antitumor agents
US6638973B2 (en) Taxane formulations
ZA200108052B (en) C10 heterosubstituted acetate taxanes as antitumor agents.
AU3481001A (en) Taxane formulations having improved solubility
US7226944B2 (en) Taxanes having a C7 carbonate substituent
US20040087547A1 (en) C7 heterosubstituted acetate taxane compositions
ZA200108058B (en) Taxane formulations having improved solubility.
US6649632B2 (en) C10 ester substituted taxanes
AU783422B2 (en) C10 carbamoyloxy substituted taxanes as antitumor agents
NZ514382A (en) C10 ester substituted taxanes as antitumor agents
NZ514410A (en) C7 carbamoyloxy substituted taxanes as antitumor agents
CA2354486A1 (en) C7 ester substituted taxanes

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE 7TH PRIORITY NUMBER TO READ USSN 60/179794